Stock Fundamentals

AI Research Report

Generate a comprehensive financial analysis report powered by AI

IKPM.JK - Current Price

$234.00

Company Information

Company Name
Ikapharmindo Putramas Tbk.
Sector
Healthcare
Industry
Pharmaceutical Retailers
Exchange
JK
ISIN: ID1000199409
Currency: IDR
Full Time Employees: 952
Phone: 62 21 460 0086
Fiscal Year End: December
Description:

PT Ikapharmindo Putramas Tbk engages in the research and development, manufacturing, and marketing of pharmaceutical products in Indonesia. It operates through three segments: Non Pharma, Pharma, and Contract Manufacturing. The company offers prescription medicines in the areas of neurology, psychiatry, dermatology, nephrology, gastroenterology, cardiology, pulmonology, antibiotics, generics, and nutraceuticals; and over-the-counter drugs. It also provides consumer health products, cosmetics, hair care products, and baby care products. PT Ikapharmindo Putramas Tbk was founded in 1978 and is headquartered in Jakarta Timur, Indonesia. PT Ikapharmindo Putramas Tbk is a subsidiary of PT Ikapharma Inti Mas.

Address:

Jl. Pulogadung Raya No. 29, Jakarta Timur, Indonesia, 13930

Directors & Officers

Name Title Year Born
Mr. . Kartono President Director 1968
Mr. Handri Widjaja Corporate Secretary & Head of Internal Audit Unit 1974

Shares Statistics

Shares Outstanding: 1.68B
Shares Float: 336.93M
% Insiders: 8,000.00%
% Institutions: 0.00%

Valuation Metrics

Enterprise Value: $394.21B
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $384.10B
EBITDA: $-6.62B
Book Value: $127.12
Profit Margin: -7.32%
Operating Margin: -25.02%
ROA (TTM): -1.89%
ROE (TTM): -12.18%
Revenue (TTM): $379.27B
Revenue/Share (TTM): $225.13
Earnings Growth (YOY): -62.30%
Revenue Growth (YOY): -13.80%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income

Operating Expenses

Balance Sheet Overview

Earnings Per Share (EPS)

Earnings History

Date EPS Actual EPS Estimate Difference Surprise %

Balance Sheet (Yearly)

Date Cash Total Debt Total Assets Total Liabilities Total Equity
2024-12-31 $23.83B $N/A $491.38B $245.25B $246.12B
2023-12-31 $44.29B $N/A $463.38B $218.67B $244.71B
2022-12-31 $10.88B $N/A $387.55B $210.85B $176.70B

Watchlist

0

No stocks in watchlist